Latest news
Jazz Pharma Expands Again in Epilepsy With $850M Actio Bio Acquisition - medcitynews.commedcitynews.com · Mon, 10 Aug 2026 22:02:41 GMTEU greenlights Recordati deal under streamlined merger scrutiny - The Brussels TimesThe Brussels Times · Mon, 10 Aug 2026 19:38:53 GMTJazz builds in epilepsy with $1.3bn Actio acquisition - pharmaphorumpharmaphorum · Mon, 10 Aug 2026 13:12:18 GMTJazz to Buy Actio Drug Candidate for Epilepsy With No FDA-Approved Therapy - Stock TitanStock Titan · Mon, 10 Aug 2026 11:30:00 GMTThe week in pharma: action, reaction and insight – week to August 7, 2026 - The Pharma LetterThe Pharma Letter · Sun, 09 Aug 2026 12:51:30 GMTAurobindo Pharma Approves Merger of Three Eugia Injectables Units - Medical DialoguesMedical Dialogues · Thu, 06 Aug 2026 13:04:53 GMTAurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms - The HinduThe Hindu · Wed, 05 Aug 2026 15:54:16 GMTRumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms - BioSpaceBioSpace · Wed, 05 Aug 2026 11:21:15 GMT